Filing metadata

Accession number
0001683168-22-001545
Form type
Form 4
Filer
CNS Pharmaceuticals, Inc.
CIK
CIK 1729427
Filed
Mar 09, 2022
Reporting period
Mar 08, 2022
Description
Insider transaction

Explore SEC Filings Hub